OverviewSuggest Edit

EdiGENE is a biotech company that develops therapeutics using its proprietary technology CRISPR-GNDM (guide nucleotide-directed modulation) for the treatment of genetic disorders. The Company’s technology platform normalizes levels of gene expression without cutting the DNA or RNA.

TypePrivate
Founded2015
HQCambridge, US
Websiteedigene.com

Locations

EdiGENE is headquartered in
Cambridge, United States

Location Map

Latest Updates

Employees (est.) (Mar 2020)17

EdiGENE Office Locations

EdiGENE has an office in Cambridge
Cambridge, US (HQ)
F18, Riverview II, 245 First St
Show all (1)

EdiGENE Financials and Metrics

Summary Metrics

Founding Date

2015

EdiGENE total Funding

$54.5 m

EdiGENE latest funding size

$15 m

Time since last funding

a year ago

EdiGENE investors

EdiGENE's latest funding round in April 2019 was reported to be $15 m. In total, EdiGENE has raised $54.5 m
Show all financial metrics

EdiGENE Online and Social Media Presence

Embed Graph

EdiGENE Frequently Asked Questions

  • When was EdiGENE founded?

    EdiGENE was founded in 2015.

  • How many employees does EdiGENE have?

    EdiGENE has 17 employees.

  • Who are EdiGENE competitors?

    Competitors of EdiGENE include Repair Biotechnologies, Freeline and Pantherna Therapeutics.

  • Where is EdiGENE headquarters?

    EdiGENE headquarters is located at F18, Riverview II, 245 First St, Cambridge.

  • Where are EdiGENE offices?

    EdiGENE has an office in Cambridge.

  • How many offices does EdiGENE have?

    EdiGENE has 1 office.